TelyRx Holdings (TELY) investor relations material

Market opportunity and business model

• Addresses the inefficiencies in traditional pharmacy by offering over 450 everyday medications delivered quickly, without appointments, insurance, or lines.

• Operates in the $98 billion cash-pay prescription market, growing at 40% annually, and avoids the regulatory hurdles faced by insurance-based competitors.

• 100% cash-pay model enables full control over the value chain, from physician access to fulfillment, with no exposure to government reimbursement regulations.

• Focuses on high-use, low-risk medications, ensuring broad reach and diversification across eight clinical categories.

• Built for scalability with two strategically located pharmacies covering 97% of the U.S. population.

Financial performance and growth

• Achieved $43 million in revenue last year, with over 50% compounded quarterly growth and 70% of revenue from repeat customers.

• Q1 revenue reached $19.4 million, up 180% year-over-year and 35% quarter-over-quarter, with gross margins expanding to 55%.

• Customer acquisition cost is $113, with a three-month payback period and average customer lifetime revenue of $524, which continues to grow.

• Marketing spend yields a 3x return, and the company has transitioned to a fully in-house marketing team to drive further efficiency.

• Gross profit margin improved from 37% to 54% in year two, with ongoing focus on margin expansion and disciplined growth.

Customer dynamics and retention

• Nearly 50% of new customers become repeat buyers, with 20% making a second purchase within seven days and 60% within 30 days.

• Average order value increases by 15% on follow-on transactions, and recurring customers drive the majority of revenue.

• Investments in customer experience and technology aim to further increase retention and lifetime value.

• Key KPIs tracked include lifetime revenue, customer acquisition cost, new vs. recurring customer mix, and prescription type distribution.

• Plans to enhance customer engagement and platform features are underway, with more updates expected in upcoming quarters.